companydata.dkcompanydata.dk

NOVO NORDISK PHARMACEUTICALS A/S: Financial statements 2014

CVR: 24257924

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

NOVO NORDISK PHARMACEUTICALS A/S (CVR 24257924) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK 3,150,000. Equity in the 2014 report amounted to DKK 12,543,000. The solvency ratio was 99.7%.

Profit/Loss
DKK 3,150,000
Equity
DKK 12,543,000
Total Assets
DKK 12,579,000

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

NOVO NORDISK PHARMACEUTICALS A/S: The 2013 annual report is outJul 27, 2014

NOVO NORDISK PHARMACEUTICALS A/S has published its annual report for 2013.

Karsten Munk Knudsen joins NOVO NORDISK PHARMACEUTICALS A/S as directorJul 1, 2014

As of July 1, 2014, Karsten Munk Knudsen is registered as director of NOVO NORDISK PHARMACEUTICALS A/S.

Lars Green steps down as adm. dir. of NOVO NORDISK PHARMACEUTICALS A/SJul 1, 2014

As of July 1, 2014, Lars Green has stepped down as adm. dir. of NOVO NORDISK PHARMACEUTICALS A/S.

About NOVO NORDISK PHARMACEUTICALS A/S

NOVO NORDISK PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named NOVO FARMAKA A/S. The management consists of Anders Rytter Mikkelsen. The board consists of Naja Eilers Barrisøe (chair), Linette Tangsgaard Nielsen and Thomas Rask Nielsen. The company is owned by NOVO NORDISK A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -53,000 and a net result of DKK 2,074,000 compared with DKK 6,918,000 the year before. Equity in the 2025 report amounted to DKK 12,325,000.

Source: annual report 2025, Danish Business Authority